Ottawa, Ontario – (Marketwired – December 6, 2016) – Tetra Bio-Pharma Inc. (“Tetra Bio” or “the Company”) (CSE: TBP and OTC: GRPOF) is conducting a non-brokered private placement with Aphria Inc. (TSX-V: APH and USOTCQB: APHQF) of 5,000,000 units at a price of $0.20 per unit for aggregate gross proceeds of $1,000,000. Each unit will consist of one common share and one non-transferable warrant, with a whole warrant entitling the holder to purchase one common share of the Company at a price of $0.26 per share for a period of 3 years following the closing date. The warrants are subject to an accelerated expiry if the Company’s shares trade above $0.45 for thirty (30) consecutive trading days then the warrants will expire in 30 days if not exercised.